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Abstract
 .A cDNA clone homologous with the human neuropeptide Y NPY -Y5 receptor has been isolated from a mouse brain
cDNA library. Analysis of the predicted amino acid sequence indicates that the polypeptide encoded by this cDNA is 89%
and 97% identical to the human and rat NPY-Y5 receptors, respectively, but has a repeat sequence of 21-amino acid
residues, unlike the human and rat NPY-Y5 receptors, in its N-terminal region. Northern blot analysis indicated that the
mouse NPY-Y5 receptor mRNA was highly expressed in the brain, but not in the heart, kidney, spleen, lung, liver, skeletal
muscle, and testis. A genomic DNA clone encoding the mouse NPY-Y5 receptor has also been cloned and used as a probe
for fluorescence in situ hybridization analysis. The mouse NPY-Y5 receptor gene consists of at least two exons with a 7.0
kbp-long intronic sequence and is localized in the chromosome 8B3-C2 region. Restriction mapping, partial sequencing, and
hybridization analysis of the mouse NPY-Y5 and NPY-Y1 receptor genes were used to determine the relationship between
the two genes in the chromosome 8B3-C2 region. The mouse NPY-Y5 receptor gene can map about 10 kbp upstream of the
transcriptional initiation sites of the NPY-Y1 receptor gene with an opposite orientation. q 1997 Elsevier Science B.V.
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 .Neuropeptide Y NPY is an important regulator in
w xthe central and peripheral nervous system 1,2 . It
belong to a family of homologous peptides including
 .the gut peptide YY PYY and pancreatic polypeptide
 .Abbreviations: NPY, neuropeptide Y; kbp, kilobase pair s ;
 .bp, base pair s ; FISH, fluorescence in situ hybridization; SDS,
sodium dodecyl sulfate; PCR, polymerase chain reaction; ORF,
open reading frame
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1  .The nucleotide sequence s reported in this paper have been
submitted to the GenBankrEMBL Data Bank under the acces-
 .sion number s AB001346.
 .PP , all of which are 36-amino acid peptides charac-
w xterized by a hairpin loop 3,4 . Studies of various
organs and cell types with peptide fragments of NPY
have indicated that multiple NPY receptor subtypes
w x  .exist 1,2 : 1 the Y1 type binds NPY, PYY, and an
w 31analog of NPY modified at residues 31 and 34 Leu ,
34 x .Pro NPY )PP and the NPY peptide C-terminal
  ..  .fragment NPY- 13–36 ; 2 the Y2 type binds NPY,
 . w 31PYY, and NPY- 13–36 ) PP and Leu ,
34 x  .Pro NPY; 3 the Y3 type binds NPY)PYY; and
 . w 31 34 x4 the Y4 type binds PP) Leu , Pro NPY)
w x w xNPY. Recently, Y1 5–11 , Y2 12–16 and Y4-type
w x17–19 receptor cDNAs were isolated and found to
have sequences similar to members of a G-protein
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coupled receptor superfamily. Moreover, the cloning
w xof the human and rat NPY-Y5 20,21 and the mouse
w xNPY-Y6 22 receptors was recently reported. The
mouse NPY-Y6 receptor has significant homology
 .56% identity with the NPY-Y1 receptor, and has
universally lost its receptor function in primate species
due to a frame shift mutation occurring early in
w xprimate evolution 23,24 . The pharmacological char-
acteristics of the NPY-Y6 receptor are distinct from
those described for the NPY-Y2, -Y3 and -Y4 recep-
tors and are similar to those described for the NPY-Y1
and ‘atypical Y1’ receptors. On the other hand, the
NPY-Y5 receptor has little identity with other previ-
ously cloned NPY receptors. This NPY-Y5 receptor
seemed to be of the NPY feeding receptor subtype
 .based on the following criteria: 1 the NPY-Y5
receptor mRNA was detected primarily in the central
nervous system, including the paraventricular hy-
pothalamic nucleus and the lateral hypothalamus,
which have been implicated in the control of feeding
w x  .behavior 1 , 2 after intracerebroventriculary injec-
  .tion of some peptides e.g. human 3–36 PYY,
 . .porcine 2–36 NPY, porcine NPY and human PP
which activated the NPY-Y5 receptor in vitro profile
.based on negative coupling to cAMP concentration ,
these peptides produced a statistically significant
w xstimulation of food intake 20 . Furthermore, the
human NPY-Y5 receptor gene is in fact just a few
kbp apart from the human NPY-Y1 receptor gene on
 . w xchromosome 4q 31.3-32 20 . The Pst I polymor-
phism near the human NPY-Y1 receptor gene was
w xalso reported 25 . However, the close relationship
between the NPY-Y1 and NPY-Y5 receptor genes,
for example short distance between the mouse NPY-
Y1 and NPY-Y5 receptor genes, has not been investi-
gated. We therefore isolated the cognate mouse NPY-
Y5 receptor cDNA from a brain cDNA library using
the rat NPY-Y5 receptor cDNA as a probe, and then
obtained the mouse NPY-Y5 receptor gene from a
mouse genomic library. We describe here the chro-
mosomal localization of the mouse NPY-Y5 receptor
gene, and provide novel information on the relation-
ship between the mouse NPY-Y1 and NPY-Y5 recep-
tor genes.
To obtain a mouse homologue of the NPY-Y5
receptor cDNA, a mouse brain cDNA library Uni-
6 .ZAP XR, 1.0=10 plaques was screened with a
 .946-base pair bp PCR-derived probe spanning amino
Fig. 1. Nucleotide sequence of the mouse NPY-Y5 receptor
 . mY5 cDNA containing the boundary nucleotide sequences of
.the exonrintron of the NPY-Y5 receptor gene . The mY5 cDNA
was sequenced using the dideoxynucleotide chain termination
w xmethod on a double-stranded template 27 . The deduced amino
acids of the mouse NPY-Y5 receptor are shown in single-letter
codes under its nucleotide sequence. The sequences of the exon
 .and intron position y9ry10 are represented by capital and
lower case letters, respectively. The seven putative transmem-
brane domains are underlined. The repeat sequences in the N-
terminal region are boxed. The potential polyadenylation signal is
double-underlined.
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Fig. 2. Alignment of the predicted amino acid sequence of the mouse NPY-Y5 receptor with the rat NPY-Y5, human NPY-Y5, mouse
NPY-Y1, the mouse NPY-Y2, the mouse NPY-Y4, and the mouse NPY-Y6 receptor sequences. Periods represent spaces added for proper
alignment. Numbers correspond to the amino acid positions of each receptor. The seven putative transmembrane domains are underlined
and numbered I–VII. Identical amino acids of the human and rat NPY-Y5 receptors to mouse protein are shown by dashes. The ‘ ’ abovea
an amino acid sequence indicates a potential N-linked glycosylation site in the N-terminal extracellular region of the mouse NPY-Y5
receptor. The repeat sequence in the N-terminal region of the mouse NPY-Y5 receptor are boxed. Residues identical among the seven
receptors are shaded in gray.
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w xacids 26–341 of the rat NPY-Y5 receptor 20,21 .
One positive clone, designated mY5, has a 2341-bp
insert DNA containing a 1398-bp open reading frame
 .  .ORF Fig. 1 . Since analysis of the predicted amino
acid sequence indicates that the polypeptide encoded
by this cDNA has seven transmembrane regions typi-
cal of G-protein coupled receptors and is 89% and
97% homologous to the human and rat NPY-Y5
receptors, respectively, it is the mouse homologue of
 .the NPY-Y5 receptor Fig. 2 . The amino acid se-
quences of the rat NPY-Y5 receptor reported by
w xGerald et al. 20 is shown as containing eleven extra
N-terminal residues as compared with that published
w xby Hu et al. 21 . The reading frame of the N-termi-
nal of the mouse NPY-Y5 receptor is in agreement
with the latter. Interestingly, the 21-amino acid repeat
sequences that were not observed in the human and
w xrat proteins 20,21 were contained in the N-terminal
 .extracellular region Figs. 1 and 2 . Furthermore,
there seem to be three N-linked glycosylation sites
 . NxSrT in its N-terminal domain two of these sites
.are in the 21-amino acid repeat sequences . A long
polyadenylation sequence was found at the 3X-end of
the clone, suggesting that the cDNA clone encom-
passes most of the mRNA species observed in the
 .Northern blot analysis Fig. 3B . Comparison of the
amino acid sequence of the mouse NPY-Y5 receptor
w xto those of the mouse NPY-Y1 7,10 , mouse NPY-Y2
w x w x w x16 , mouse NPY-Y4 19 and mouse NPY-Y6 22
receptors reveals extensive differences. As shown in
Fig. 2, at the amino acid level the mouse NPY-Y5
receptor exhibits low overall identities of 26%, 22%,
25% and 25% with the NPY-Y1, NPY-Y2, NPY-Y4
and NPY-Y6 receptors, respectively. The alignment
 .scores for the transmembrane TM domains are 45%,
45%, 44% and 40% identity with the NPY-Y1, NPY-
Y2, NPY-Y4 and NPY-Y6 receptors, respectively.
Interestingly, a high identity was observed in the
TM7 domain of these receptors. Southern blot analy-
sis of the mouse genomic DNA indicated the pres-
 .Fig. 3. Southern and Northern blot analyses. A Southern blot analysis of a mouse genomic DNA. Mouse genomic DNA was digested
 .  .  .  .  . 32with HindIII lane 1 , KpnI lane 2 , SacI lane 3 , BamHI lane 4 , or EcoRI lane 5 . By using the P-labeled mY5 cDNA as a probe,
 .hybridization was carried out at 658C for 2 h in Rapid Hybridization Buffer Amersham and the filter was washed at 658C for 30 min in
 .0.2=SSC containing 0.1% SDS. B Northern blot analysis of the mouse NPY-Y5 receptor mRNA. Mouse Multiple Tissue Northern
Blot that contained 2 mg of mRNA from various sources was purchased from Clontech. By using the mY5 cDNA as a probe,
hybridization was carried out at 658C for 2 h in Rapid Hybridization Buffer, and the filter was successively washed at 658C for 20 min in
2=SSC containing 0.1% SDS and then at 658C for 30 min in 0.2=SSC containing 0.1% SDS. Each lane contains 2 mg of mRNA. Lane
1, heart; lane 2, brain; lane 3, spleen; lane 4, lung; lane 5, liver; lane 6, skeletal muscle; lane 7, kidney; lane 8, testis.
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ence of single HindIII, KpnI, SacI, BamHI or EcoRI
restriction fragments, when probed with the full-
 .length cDNA of the mY5 clone Fig. 3A . This result
means that there is a single NPY-Y5 receptor gene.
The expression of the receptor mRNA in various
mouse tissues was investigated by Northern blot anal-
 .ysis Fig. 3B . Among them, only brain showed a
band in the range of about 2.5 kilobases. No signal
was obtained from any of the other peripheral tissues,
such as heart, spleen, lung, liver, skeletal muscle,
kidney, or testis. This expression pattern is almost
w xidentical to that of the rat NPY-Y5 receptor 20,21 .
To further investigate the genomic structure of the
mouse NPY-Y5 receptor gene, we isolated its ge-
nomic clones. Upon screening approximately 1.0=
6 10 plaques of a mouse genomic DNA library lFIX
.  .II with the mY5 cDNA full-lenght as a probe, we
obtained three positive clones. Two of them, lgY5-1
 . approximately 12 kbp long and lgY5-2 approxi-
.mately 20 kbp long , were subjected to extensive
characterization. Restriction mapping of these clones
are shown in Fig. 4A. Partial sequence and Southern
blot analyses revealed that lgY5-2 contained the
entire NPY-Y5 receptor ORF, including the 5X- and
X  .3 -untranslated regions Figs. 1 and 4 . As shown in
Figs. 1 and 4, the mouse NPY-Y5 receptor gene has
at least one intron. This intron, approximately 7.0
kbp long, was located at position y9ry10 in the
5X-untranslated region of the NPY-Y5 receptor cDNA.
Sequences around the putative junction are shown in
Fig. 1. The nucleotide sequence of the intron adjoin-
ing the splice junction is the recognized consensus
sequence GTrAG. Hu et al. reported that one of the
isolated rat cDNA clones contained a 123-bp inser-
tion at position y9ry10 in the 5X-untranslated re-
 .gion and suggested the existence of intron s in this
w xportion of the rat NPY-Y5 receptor gene 21 . The
position of this insertion is consistent with the loca-
tion of the intron of the mouse NPY-Y5 receptor
gene.
w xRecently, Gerald et al. 20 reported that the hu-
man NPY-Y5 and NPY-Y1 receptor genes could map
to the same locus but with an opposite orientation,
because the reverse complement sequences of the
human NPY-Y5 coding region transmembrane do-
.main VI-VII and carboxy tail regions showed a
99.6% match with the exon 1C region including its
. Xflanking sequences located in the 5 -noncoding re-
gion of the Y1C alternate splice variant mRNA of the
w xhuman NPY-Y1 receptor 25,26 . To confirm the
close relationship between the mouse NPY-Y5 and
NPY-Y1 receptor genes, we compared the restriction
mapping and sequences of the isolated NPY-Y5 re-
ceptor genomic clones with those of the previously
 .Fig. 4. A Structure of the mouse NPY-Y5 and NPY-Y1 recep-
tor genes. The isolated mouse genomic clones lgY5-1 and
lgY5-2 for the NPY-Y5 receptor gene, and lgY1-1, lgY1-2 and
.lgY1-3 for the NPY-Y1 receptor gene are indicated by horizon-
tal bars above the gene. The closed and the open boxes indicate
coding and noncoding regions in the exons, respectively. Perti-
nent restriction enzyme sites are noted B, BamHI; H, HindIII;
.X, XhoI . The transcriptional start points of the NPY-Y1 receptor
w xgene were determined by Eva et al. 7 , whereas those of the
 .NPY-Y5 receptor gene are still unknown. B Chromosomal
mapping of the mouse NPY-Y5 and NPY-Y1 receptor genes by
 .fluorescence in situ hybridization FISH analysis. Mouse chro-
mosome 8 is shown schematically. The R-banding for direct
mapping with FISH was carried out according to the method of
w xTakahashi et al. 28,29 . Plasmid containing the mouse NPY-Y5
or NPY-Y1 receptor genomic clones, lgY5-2 or lgY1-2, was
labeled with biotin-16-dUTP using a nick translation kit Boeh-
.ringer Mannheim according to the supplier’s instruction. The
FISH procedure was carried out according to the method of Trask
w xet al. 30,31 .
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isolated mouse NPY-Y1 receptor genomic clones
 . w xlgY1-1, lgY1-2 and lgY1-3 10 . We previously
showed that the mouse NPY-Y1 receptor gene com-
prised three exons with a 6.5 kbp 5X-noncoding and a
w x108-bp internal intronic sequences 10 ; the multiple
transcriptional initiation sites of the mouse NPY-Y1
w xreceptor gene were determined by Eva et al. 7 .
Partial sequence, restriction mapping, and Southern
blot analysis of these genomic clones revealed that
X  .the 5 -end region approximately 2 kbp of one of the
 .isolated NPY-Y1 receptor genomic clone lgY1-3
was an exact match for the reverse sequence of the
X  .5 -end region of the lgY5-2 clone Fig. 4A . These
results taken together indicate that the 5X-noncoding
 .exon referred to as exon1 in Fig. 4A of the mouse
NPY-Y5 receptor gene can map about 10 kbp up-
stream of the transcriptional initiation sites of the
NPY-Y1 receptor gene with an opposite orientation.
Next, to further determine the chromosomal localiza-
tion of the mouse NPY-Y5 gene, metaphase chromo-
some from mouse lymphocytes showing typical R-
bands were examined using the DNA fragment of
lgY5-2 as a probe. The fluorescence signals ob-
served with the probe for the NPY-Y5 gene were
specific to chromosome 8B3-C2 99 signals out of a
.total of 137 signals, P-0.01 , as identified from
 .R-banding pattern Fig. 4B . There was no other
significant signal cluster on any other chromosomes.
This result demonstrates that there is a single gene
for the mouse NPY-Y5 receptor localized in the
region of chromosome 8B3-C2. The same localiza-
tion was observed by using the mouse NPY-Y1
receptor genomic clone, lgY1-2, as a probe 95
.signals out of a total of 134 signals, P-0.01 .
Interestingly, the regions where the mouse NPY-Y5
and NPY-Y1 receptor genes are localized are not in a
region homologous with human chromosome
 .4q 31.3-32 where the gene for the human NPY-Y1
w xreceptor maps 25 .
In summary, we have presented the structure and
genomic localization of the mouse NPY-Y5 receptor.
These observation might have important implications
and it will be interesting to determine whether this
locus is associated with eating disorders or obesity in
mouse.
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